Amicus Therapeutics, Inc. (FOLD)
9.895
+0.04
(+0.46%)
USD |
NASDAQ |
Dec 11, 16:00
9.895
0.00 (0.00%)
After-Hours: 20:00
Amicus Therapeutics Research and Development Expense (TTM): 142.29M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| CorMedix, Inc. | 12.46M |
| ACADIA Pharmaceuticals, Inc. | 344.78M |
| ANI Pharmaceuticals, Inc. | 56.05M |
| Beam Therapeutics, Inc. | 411.79M |
| Catalyst Pharmaceuticals, Inc. | 14.70M |